Patrick G. Lepore, Director at VYNE Therapeutics Inc. (VYNE), bought 12,500 shares at $1.60 ($20K) on 2021-08-25, disclosed to the SEC on 2021-08-26.
Recurring purchase ($20k) by Director following this insider's established cadence. Pattern-driven, low signal.
Something here stands out, but not much.
| Filing → |
| VYNE | BUY | 2023-03-22 | $50K | — | Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |